Animal health is a multi-billion-dollar market that has undergone rapid growth in recent years and a positive confluence of factors make this a potentially attractive area for investors. The sector is made up of companion animal (pets) and livestock (farm animal) with companies offering drugs, vaccines, medicated animal feeds and diagnostic products. The growing awareness about animal diseases, a greater focus on prevention from disease and increasing regulations provide an attractive set-up for the sector. Further growth is anticipated due to increased pet ownership, higher medical expenditure and increased use of more sophisticated therapeutics and diagnostics. Quilter Cheviot's Equity Research Analyst Sheena Berry elaborates on the topic and shares some insights about investment oportunities in the sector.

Compared to human health, animal health experiences shorter and cheaper development timelines, reduced payer complexity in what is largely a cash pay market, less reliance on blockbuster drugs and less exposure to patent cliffs.

The companion animal market experienced elevated growth during the Covid-19 pandemic due to a significant pick-up in pet ownership. It has been reported that more than half of the global population has a pet at home, with many owners increasingly viewing pets as family members- the ‘humanisation’ of pets. Millennials (those born between 1981 and 1996 inclusive) and Gen Z (those born from 1997 onward) have driven the growth in the pet population and are the pet owners more likely to make financial trade-offs to accommodate pet-related expenditures.

An area within animal health that offers attractive growth is diagnostics, where utilisation remains low, and vets are increasingly integrating products. Diagnostics helps to give pet owners insights and information on their animals through both reference lab and point-of-care testing. This offers valuable insight into the animal’s health status, particularly given pets are unable to speak about their conditions. The space is relatively concentrated with IDEXX laboratories as the clear market leader. Zoetis is newer to the diagnostic space having expanded into it with an acquisition in 2018.

The other main segment within animal health is livestock, where the drivers are different to companion animals, in part due to the market being more commercial and different owner requirements. Unlike companion animal owners, where the animals form more of an emotional bond, livestock owners are farmers looking for cost-effective and sustainable production of safe, high-quality animal protein. The primary motivation is to make money.

The global human population is expected to continue growing, which naturally leads to an increase in food consumption. The proportion of protein is not expected to change materially over the coming decade, with demand for higher-quality protein and dairy products set to remain robust. The types of drugs used on these animals are largely those to prevent infection, increase yield and meet regulatory requirements.

While livestock is the larger market, the companion animal segment of animal health is faster growing and typically generates a higher margin.

The animal health market is fragmented with the larger players including Zoetis, Boehringer Ingelheim’s animal health division, Merck animal health, Elanco and IDEXX Laboratories. Zoetis is the largest player in the animal health space with a diversified portfolio that includes fifteen blockbusters (annual sales of over US$100m). The group’s newer products, which include the first triple combination parasiticide for dogs (Simparica Trio) and monoclonal antibody therapies for the alleviation of osteoarthritis pain in dogs and cats (Librela and Solensia), should contribute to the group continuing to deliver above market growth.

Smaller companies include Dechra, Heska and Phibro Animal Health. Dechra’s portfolio is relatively resilient with around 70% requiring a prescription and whilst the group has no blockbuster products, it has a broad portfolio with a focus on innovation and bringing more novel products to the market as highlighted through an acquisition in 2022 of a company with eight pipeline candidates.

In terms of share price performance, the animal health sub-sector lagged the wider market in 2022 after a strong 2021, due to concerns around the durability of the pet health market. Whilst there may be some volatility in the short term, the animal health sector offers attractive growth aided by two important trends: increased average spend per pet and the growing demand globally for higher quality protein.

Investing in Animal Health

Sheena joined Quilter Cheviot in May 2018 to analyse stocks within the Healthcare sector.

Prior to joining Quilter Cheviot, Sheena was a Life Sciences analyst at N+1 Singer.

Equity Research Analyst

Sheena Berry

As a wealth manager, Quilter Cheviot utilises its expertise in both Investment Management and Financial Planning to deliver a comprehensive and holistic service. This allows them to create bespoke financial plans and investment portfolios specifically designed to meet clients’ individual needs.

Quilter Cheviot’s Investment Managers have been trusted to help grow and preserve clients’ wealth for over 250 years. Their heritage dates back to 1771, and they have offices in several regions in the UK, in Dublin, Dubai and Jersey.

Quilter Private Client Advisers treats every financial journey as unique. They have a dedicated team focused on delivering a truly personalised service, always holding clients' interests at heart. They follow a holistic approach that enables them to develop a lifelong financial plan for clients, based on individual finances and aspirations. They offer a wide range of advice including, but not limited to, first home purchases, considerations around retirement and passing on wealth. 

Quilter Private Client Advisers also works alongside both Quilter Cheviot, it's sister company and award-winning discretionary fund management firm, and many professionals involved in managing clients' financial affairs, to help them deliver a comprehensive service. 

Quilter Cheviot is one of the largest discretionary investment management firms across the UK, Ireland and Channel Islands, managing bespoke investment portfolios for individuals and families for generations. Quilter Cheviot has over 36,000 clients and £25.9 billion of AUM (as at 31 March 2023).

Each client is assigned an experienced, dedicated Investment Manager who will create and manage their investment portfolio to help them achieve their own specific goals at every life stage. Their investment Managers have an average of over 16 years’ industry experience, with over 10 years at Quilter Cheviot.

Quilter Cheviot's Investment Managers are supported by one of the largest in-house research teams in the discretionary industry, consisting of 22 analysts covering equity, fixed interest and collective (fund).

Quilter Cheviot

Poppy's primary role is the management of private client, trust and pension portfolios working with both intermediaries and direct clients. She tries to build long term relationships with her clients and their advisers with the aim to provide excellent service.

Poppy joined Quilter Cheviot in 2020 having spent over 13 years at Brooks Macdonald. Poppy joined Brooks Macdonald in 2006 where she had various roles, latterly as an Investment Director.

Investment director

As a discretionary investment manager, Andrew helps clients on their journey towards achieving their financial goals. He works closely with individuals, families, business owners, trustees, intermediaries, and pension schemes. Andrew enjoys finding out what is important to them and helping them understand, often complex, investment matters in a clear and simple way.

He has over 20 years’ experience in the investment industry. Prior to joining Quilter Cheviot in 2021, Andrew worked at Brewin Dolphin, as an investment manager, and Barclays Wealth where he led the national UK Equities Committee.

Investment Manager

Nigel's primary role is managing portfolios for private clients, pension funds, companies, and charities, ensuring that his clients’ get the best service Quilter Cheviot can offer, guiding them through investment choices that occur during their lifetime.

Having commenced his investment management career with Adams & Remers solicitors in Sussex, he gained significant experience at Berry Asset Management (latterly Bordier & Cie) before helping to set-up Quartet Capital Partners in 2010, where he was Partner. Nigel joined Quilter Cheviot in early 2013.

He's proud to have made the PAM top 40 under 40 list two years in a row. This programme is established as a guide to rising stars in the private banking and private asset management sectors.

Sheena Berry

Bio

Articles from author

Investing in Animal Health

Start your journey to your
Financial well-being

FIND OUT MORE

LEGAL

CONTACT US

Sheena Berry

Bio

Articles from author

Investing in Animal Health

Start your journey to your Financial well-being

FIND OUT MORE

LEGAL

CONTACT US

Start your journey to your
Financial well-being